Anna P. Schenck

1.8k total citations
53 papers, 1.4k citations indexed

About

Anna P. Schenck is a scholar working on General Health Professions, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna P. Schenck has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in General Health Professions, 14 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna P. Schenck's work include Global Cancer Incidence and Screening (12 papers), Colorectal Cancer Screening and Detection (9 papers) and Palliative Care and End-of-Life Issues (9 papers). Anna P. Schenck is often cited by papers focused on Global Cancer Incidence and Screening (12 papers), Colorectal Cancer Screening and Detection (9 papers) and Palliative Care and End-of-Life Issues (9 papers). Anna P. Schenck collaborates with scholars based in United States, South Africa and United Kingdom. Anna P. Schenck's co-authors include Carrie N. Klabunde, William W. Davis, Sharon Peacock, Laura C. Hanson, Cathleen Colón‐Emeric, Dana Loomis, Franziska S. Rokoske, David A. Savitz, E Gregory and S R Browning and has published in prestigious journals such as Annals of Internal Medicine, Diabetes Care and American Journal of Public Health.

In The Last Decade

Anna P. Schenck

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna P. Schenck United States	21	544	377	281	261	236	53	1.4k
Romain Neugebauer United States	24	411 0.8×	258 0.7×	192 0.7×	193 0.7×	127 0.5×	92	2.3k
Neil R. Bell Canada	23	302 0.6×	589 1.6×	359 1.3×	387 1.5×	285 1.2×	76	1.8k
Lisa Stirk United Kingdom	19	240 0.4×	440 1.2×	239 0.9×	270 1.0×	186 0.8×	43	1.5k
Judith M. E. Walsh United States	23	1.1k 2.0×	451 1.2×	416 1.5×	264 1.0×	421 1.8×	71	3.0k
Kiheon Lee South Korea	20	259 0.5×	119 0.3×	222 0.8×	155 0.6×	111 0.5×	75	1.3k
K Bjartveit Norway	16	178 0.3×	163 0.4×	439 1.6×	159 0.6×	100 0.4×	44	1.5k
Jeffrey A. Henderson United States	21	236 0.4×	483 1.3×	381 1.4×	278 1.1×	89 0.4×	51	2.0k
Lisa Iversen United Kingdom	25	426 0.8×	428 1.1×	658 2.3×	149 0.6×	168 0.7×	56	2.2k
Kate M. Brett United States	20	400 0.7×	249 0.7×	306 1.1×	173 0.7×	51 0.2×	34	1.8k
Lydia Guittet France	23	788 1.4×	162 0.4×	154 0.5×	380 1.5×	655 2.8×	61	1.8k

Countries citing papers authored by Anna P. Schenck

Since Specialization

Citations

This map shows the geographic impact of Anna P. Schenck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna P. Schenck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna P. Schenck more than expected).

Fields of papers citing papers by Anna P. Schenck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna P. Schenck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna P. Schenck. The network helps show where Anna P. Schenck may publish in the future.

Co-authorship network of co-authors of Anna P. Schenck

This figure shows the co-authorship network connecting the top 25 collaborators of Anna P. Schenck. A scholar is included among the top collaborators of Anna P. Schenck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna P. Schenck. Anna P. Schenck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahsan, Karar Zunaid, et al.. (2025). Advancing Pedagogy in Leadership Practice to Enhance Public Health Impact. Journal of Public Health Management and Practice. 31(4). 515–526.

Drake, Amelia F., et al.. (2023). Building diverse leadership in an academic medical center: The ACCLAIM program. Journal of the National Medical Association. 115(2). 134–143. 2 indexed citations

Blessington, Tyann, Anna P. Schenck, & Jay F. Levine. (2020). Frequency of Animal Leptospirosis in the Southern United States and the Implications for Human Health. Southern Medical Journal. 113(5). 240–249. 2 indexed citations

Schenck, Anna P., et al.. (2018). Senior PharmAssist: Less Hospital Use with Enrollment in an Innovative Community‐Based Program. Journal of the American Geriatrics Society. 66(12). 2394–2400. 7 indexed citations

Davis, Mary V., Christine A. Bevc, & Anna P. Schenck. (2014). Effects of Performance Improvement Programs on Preparedness Capacities. Public Health Reports. 129(6_suppl4). 19–27. 10 indexed citations

Schenck, Anna P., Carrie N. Klabunde, Joan L. Warren, et al.. (2011). Physician visits and colorectal cancer testing among Medicare enrollees in North Carolina and South Carolina, 2005.. PubMed. 8(5). A112–A112. 2 indexed citations

Wheeler, Stephanie B., William R. Carpenter, Jeffrey Peppercorn, et al.. (2011). Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer. Breast Cancer Research and Treatment. 131(1). 207–216. 21 indexed citations

Hanson, Laura C., Leslie P. Scheunemann, Sheryl Zimmerman, Franziska S. Rokoske, & Anna P. Schenck. (2010). The PEACE Project Review of Clinical Instruments for Hospice and Palliative Care. Journal of Palliative Medicine. 13(10). 1253–1260. 29 indexed citations

Carson, April P., Daniel L. Howard, William R. Carpenter, et al.. (2010). Trends and Racial Differences in the Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer. Journal of Pain and Symptom Management. 39(5). 872–881. 13 indexed citations

10.

Arora, Tarun, et al.. (2009). Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research. Osteoporosis International. 20(11). 1921–1927. 8 indexed citations

11.

Schenck, Anna P., et al.. (2008). Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporosis International. 19(8). 1225–1233. 51 indexed citations

12.

Colón‐Emeric, Cathleen, Kenneth W. Lyles, Deborah A. Levine, et al.. (2007). Randomized Trial to Improve Fracture Prevention in Nursing Home Residents. The American Journal of Medicine. 120(10). 886–892. 55 indexed citations

13.

Schenck, Anna P., et al.. (2006). Increasing colorectal cancer testing: translating physician interventions into population-based practice.. PubMed. 27(3). 25–35. 4 indexed citations

14.

Klabunde, Carrie N., Anna P. Schenck, & William W. Davis. (2006). Barriers to Colorectal Cancer Screening Among Medicare Consumers. American Journal of Preventive Medicine. 30(4). 313–319. 152 indexed citations

15.

Colón‐Emeric, Cathleen, et al.. (2006). Translating Evidence‐Based Falls Prevention into Clinical Practice in Nursing Facilities: Results and Lessons from a Quality Improvement Collaborative. Journal of the American Geriatrics Society. 54(9). 1414–1418. 45 indexed citations

16.

Colón‐Emeric, Cathleen, Kenneth W. Lyles, Deborah A. Levine, et al.. (2006). Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporosis International. 18(4). 553–559. 62 indexed citations

17.

Brown, David W., Janet B. Croft, Anna P. Schenck, et al.. (2004). Inpatient smoking-cessation counseling and all-cause mortality among the elderly. American Journal of Preventive Medicine. 26(2). 112–118. 42 indexed citations

18.

Sueta, Carla A., et al.. (2003). Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients ≥65 years hospitalized with a left ventricular ejection fraction ≥50%**The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The investigator assumes full responsibility for the accuracy and completeness of the ideas presented. This study is a direct result of the Health Care Quality Improvement Program initiated by the Centers for Medicare & Medicaid Services, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this contractor. Ideas and contributions to the investigator concerning experience in engaging with issues presented are welcomed.. The American Journal of Cardiology. 91(3). 363–365. 15 indexed citations

19.

Sueta, Carla A., et al.. (2000). Effect of angiotensin-converting enzyme inhibitor therapy on 30-day outcome in patients ≥65 years of age with chronic congestive heart failure∗∗The analyses upon which this publication is based were performed under contract number 500-96-P613, entitled “Operation of Utilization and Quality Control Peer Review Organization (PRO) for the state of North Carolina, sponsored by the Health Care Financing Administration, Department of Health and Human Services.” The conclusions and opinions expressed, and methods used herein are those of the investigators. They do not necessarily reflect Health Care Financing Administration policy. The investigators assume full responsibility for the accuracy and completeness of the ideas presented.. The American Journal of Cardiology. 86(10). 1151–1153. 7 indexed citations

20.

McMahon, Michael, Rongling Li, Anna P. Schenck, Andrew F. Olshan, & Rachel A. Royce. (1997). Previous cesarean birth. A risk factor for placenta previa?. PubMed. 42(7). 409–12. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact